Literature DB >> 15592674

[Intraductal neoplasms of the pancreas: cystic and common].

G Klöppel1, M Kosmahl, J Lüttges.   

Abstract

The most important of the generally rare intraductal tumors of the pancreas is the intraductal papillary-mucinous neoplasm (IPMN). In recent years this tumor type has been described in detail, and it was included in the WHO classification of 1996. IPMNs typically grow for a long time within the ducts, before approximately 50% of them eventually become invasive. Because of this feature the IPMNs are clearly distinct from ductal adenocarcinomas. Currently, IPMNs have advanced to the most commonly resected cystic tumor of the pancreas. Recent studies have shown that IPMNs may be distinguished into different types showing a different biology according to their mucin pattern.

Entities:  

Mesh:

Year:  2005        PMID: 15592674     DOI: 10.1007/s00292-004-0728-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  35 in total

1.  Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms.

Authors:  Hiroaki Shibahara; Shugo Tamada; Masamichi Goto; Koji Oda; Masato Nagino; Tetsuro Nagasaka; Surinder K Batra; Michael A Hollingsworth; Kohzoh Imai; Yuji Nimura; Suguru Yonezawa
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

2.  Microsatellite instability in intraductal papillary neoplasms of the biliary tract.

Authors:  Susan C Abraham; Jae-Hyuk Lee; John K Boitnott; Pedram Argani; Emma E Furth; Tsung-Teh Wu
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

3.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

Authors:  F Maire; P Hammel; B Terris; F Paye; J-Y Scoazec; C Cellier; M Barthet; D O'Toole; P Rufat; C Partensky; E Cuillerier; P Lévy; J Belghiti; P Ruszniewski
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

5.  Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination.

Authors:  F Paye; A Sauvanet; B Terris; P Ponsot; V Vilgrain; P Hammel; P Bernades; P Ruszniewski; J Belghiti
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

6.  Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas.

Authors:  Toshio Nakagohri; Takehide Asano; Takashi Kenmochi; Tetsuro Urashima; Takenori Ochiai
Journal:  World J Surg       Date:  2002-06-06       Impact factor: 3.352

7.  Intraductal papillary neoplasia of the liver associated with hepatolithiasis.

Authors:  T C Chen; Y Nakanuma; Y Zen; M F Chen; Y Y Jan; T S Yeh; C T Chiu; T T Kuo; J Kamiya; K Oda; M Hamaguchi; Y Ohno; L L Hsieh; Y Nimura
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

8.  Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients.

Authors:  C Azar; J Van de Stadt; F Rickaert; M Devière; M Baize; G Klöppel; M Gelin; M Cremer
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

9.  Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.

Authors:  F Sessa; E Solcia; C Capella; M Bonato; A Scarpa; G Zamboni; N S Pellegata; G N Ranzani; F Rickaert; G Klöppel
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  7 in total

Review 1.  Intraductal papillary mucinous neoplasia (IPMN) of the pancreas: its diagnosis, treatment, and prognosis.

Authors:  Robert Grützmann; Stefan Post; Hans Detlev Saeger; Marco Niedergethmann
Journal:  Dtsch Arztebl Int       Date:  2011-11-18       Impact factor: 5.594

Review 2.  [Cystic lesions of the pancreas].

Authors:  B Buerke; C Schülke
Journal:  Radiologe       Date:  2015-02       Impact factor: 0.635

Review 3.  Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease.

Authors:  Jens Werner; Stefan Fritz; Markus W Büchler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-03-06       Impact factor: 46.802

Review 4.  [Cystic tumors of the pancreas].

Authors:  R Grützmann; H-D Saeger
Journal:  Chirurg       Date:  2010-08       Impact factor: 0.955

Review 5.  Radiomics in stratification of pancreatic cystic lesions: Machine learning in action.

Authors:  Vipin Dalal; Joseph Carmicheal; Amaninder Dhaliwal; Maneesh Jain; Sukhwinder Kaur; Surinder K Batra
Journal:  Cancer Lett       Date:  2019-10-17       Impact factor: 8.679

Review 6.  The Clinical and Socio-Economic Relevance of Increased IPMN Detection Rates and Management Choices.

Authors:  Christoph Budde; Georg Beyer; Jens-Peter Kühn; Markus M Lerch; Julia Mayerle
Journal:  Viszeralmedizin       Date:  2015-02

Review 7.  Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.

Authors:  Antonio Gnoni; Antonella Licchetta; Aldo Scarpa; Amalia Azzariti; Anna Elisabetta Brunetti; Gianni Simone; Patrizia Nardulli; Daniele Santini; Michele Aieta; Sabina Delcuratolo; Nicola Silvestris
Journal:  Int J Mol Sci       Date:  2013-09-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.